Results 71 to 80 of about 4,857 (187)
Therapeutic Advances in Drug Safety, 2019 Background: Neuropsychiatric symptoms (NPS) in dementia impact profoundly on the quality of life of people living with dementia and their care givers. Evidence for the effectiveness and safety of current therapeutic options is varied.
Jodie Belinda Hillen +3 more
doaj +1 more source
Refractory OCD Due to Thalamic Infarct With Response to Dronabinol [PDF]
, 2016 Joseph J. Cooper, Jon E. Grant
openalex +1 more source
Dronabinol Useful for Chronic Pain: A Case Report [PDF]
, 2023 Robert N Agnello
openalex +1 more source
Impact of Dronabinol on Quantitative Electroencephalogram (qEEG) Measures of Sleep in Obstructive Sleep Apnea Syndrome [PDF]
, 2014 Sarah S. Farabi +3 more
openalex +1 more source
0558 DRONABINOL REDUCES AHI AND DAYTIME SLEEPINESS IN PATIENTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNEA SYNDROME [PDF]
, 2017 D. W. Carley +9 more
openalex +1 more source
0451 Dronabinol Plus Acetazolamide for the Treatment of Obstructive Sleep Apnoea: A Proof of Concept and Mechanistic Exploration Study [PDF]
, 2023 Luke D. J. Thomson +14 more
openalex +1 more source
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2018 Background and Objectives: Tetrahydrocannabinol (THC) is a psychoactive substance that affects the central nervous system. Acetylcholinesterase enzyme, as one of the enzymes of central and peripheral nervous system, plays a role in the sympathetic and ...
Nafiseh Shafiei +2 more
doaj
Analyzing Medwatch Data in an Effort to Assess Dronabinol Post-Marketing Safety [PDF]
, 2017 Rohan Ramnarain
openalex +1 more source
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial [PDF]
, 2004 Kristina B. Svendsen +2 more
openalex +1 more source